TipRanks
Go Ultimate55% OFF

Spire Healthcare (S00) AI Stock Analysis

DE:S00

Spire Healthcare

(Frankfurt:S00)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Sustained Revenue ExpansionThe substantial multi-year revenue increase indicates durable demand for Spire’s private healthcare, diagnostics and publicly funded services. Continued volume growth gives the group a broader base over which to spread hospital and clinical operating costs.
Negative Factors
Elevated LeverageHigh leverage leaves less balance-sheet protection if patient volumes, reimbursement or margins weaken. It can also increase sensitivity to financing costs and restrict capital allocation, making expansion and investment more dependent on cash-flow stability.

Spire Healthcare (S00) vs. iShares MSCI Germany ETF (EWG)

-40%-30%-20%-10%0%10%20%30%DE:S00+13.66%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 997.49M
Dividend Yield
0.57%
Average Volume (3M)
1,486
Price to Earnings (P/E)
-529.8
Beta (1Y)
-0.03
Revenue Growth
-1.38%
EPS Growth
-110.24%
Country
Germany
Employees
17,800
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Spire Healthcare Business Overview & Revenue Model

Company Description

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case...

Spire Healthcare Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:S00 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:NIOXGB:NIOX68NeutralGBP 273.94M40.4810.01%2.29%3.26%32.54%
GB:CRWGB:CRW60NeutralGBP 356.58M25.055.94%3.20%-3.45%-1.68%
GB:OPTGB:OPT56NeutralGBP 269.22M156.650.83%―14.84%-15.14%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
GB:PRTCGB:PRTC50NeutralGBP 287.84M157.160.14%―-4.11%-96.92%
GB:AGYGB:AGY42NeutralGBP 253.30M-4.04409.00%―2.94%-32.00%

* Healthcare Sector Average

Performance Comparison

-40%-20%0%20%DE:S00GB:AGYGB:NIOXGB:CRWGB:PRTCGB:OPTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:S00 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:S00Spire Healthcare2.820.3212.75%
GB:AGYAllergy Therapeutics4.00-4.90-55.06%
GB:NIOXCircassia Pharmaceuticals67.601.311.98%
GB:CRWCraneware Plc1048.00-1159.15-52.52%
GB:PRTCPureTech Health117.40-12.40-9.55%
GB:OPTOptima Health PLC247.5046.0322.85%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.